What an exciting day at the Lakeview Senior Center! We showcased our commitment to health and wellness at the Annual Healthy Living Expo in Irvine. 🎉 It was fantastic connecting with everyone who visited our booth. 💪❤️ #HealthyLivingExpo #IrvineEvents

Join us for the Walk to End Alzheimer's! 💜 Lace up your sneakers to support our community in raising awareness and funds for Alzheimer's research. Together, we can honor those affected and strive for a future where Alzheimer’s is just a memory. #WalkToEndAlz #EndAlzheimers

💜 At Syrentis, we’re passionate about combating Alzheimer's! 💜 Our dedicated team is committed to raising awareness and supporting impactful research. Together, we stand with our community in this fight. Let’s keep pushing for progress—every effort counts! #SyrentisCares #ALZ

Are you or someone you love experiencing memory loss? Learn more about an opportunity to participate in a clinical study. Learn more. (800) NEW-STUDY | Syrentis.com #alzheimers #endalz #dementia #alzheimersawareness #momentsmatter #earlyalzheimers #AltitudeAD

We are currently testing an investigational medication for people living with MDD. You may be eligible to participate. Learn more. (800) NEW-STUDY | Syrentis.com #depressionstudy #depressiontreatment #depression #clinicaltrials #MentalHealthMatters

ReGen-Brain is a Phase 2 clinical trial of allopregnanolone (ALLO) to evaluate its effectiveness as a therapeutic to regenerate brain structure and function in people with mild #Alzheimers disease. Learn more. (800) NEW-STUDY | Syrentis.com #ReGenBrain #ClinicalTrials

Do you have ADHD and are you between the ages of 18 to 55? A local research clinic is currently seeking volunteers for a study near you. Learn more. (800) NEW-STUDY | Syrentis.com #ADHDawareness #ADHDresearch #ADHDstudy #clinicaltrials #SyrentisClinicalResearch

Children, adolescents, and adults diagnosed with Tourette’s Disorder may qualify to participate in a clinical study. To learn more, contact us today. (800) NEW-STUDY | Syrentis.com #tourettes #ticsdisorder #tourettesstudy #ClinicalTrial #SyrentisClinicalResearch

If you think a someone you love has binge eating disorder, they may be eligible to participate in this research study. Find out more. (800) NEW-STUDY | Syrentis.com #BingeEatingDisorder #BED #ClinicalTrials #SyrentisClinicalResearch

People with Mild Cognitive Impairment may qualify for the TargetTau-1 clinical trial. Learn more. (800) NEW-STUDY | Syrentis.com #memory #MCI #TargetTau1Study #Alzheimers #ClinicalTrials #SyrentisClinicalResearch

The HOPE study is evaluating a new, wearable device to potentially treat or slow the progression of Alzheimer’s disease using sensory stimulation. Learn more. (800) NEW-STUDY | Syrentis.com #HOPEstudy #Alzheimers #EndALZ #ClinicalTrials #SyrentisClinicalResearch

A clinical research study for adults living with treatment-resistant depression is enrolling. Prequalify Today for Investigational Study. Contact us today. (800) NEW-STUDY | Syrentis.com #Depression #TreatmentResistantDepression #ClinicalTrials #MentalHealthMatters

We are participating in the Alzheimer's Association Walk to End Alzheimer's for the nearly 7 million Americans living with the disease. Join our team or support me with a donation! Together, we can end Alzheimer's. act.alz.org/site/TR?fr_id=…

People with mild memory problems are mission critical to finding new treatments to slow down #Alzheimers disease. Learn more about the BENFOTEAM clinical research trial at (site name)!(800) NEW-STUDY | Syrentis.com #BenfoTeam #MildAlzheimers #MCI #ClinicalTrials

Join this clinical research study evaluating an investigational medication to reduce the risk of atrial fibrillation (AF or #AFib) complications. Call today! (800) NEW-STUDY | Syrentis.com #Atrialfibrillation #clinicaltrials #SyrentisClinicalResearch

Your depression doesn’t have to win. Join JUNIPER MDD study at no cost and test a new investigational depression option that might help you. Contact us today. (800) NEW-STUDY | Syrentis.com #MentalHealthMatters #depressiontreatment #depressionawareness #ClinicalTrial

Dealing with Mild Cognitive Impairment? You may qualify for our study. Travel and study treatment for our #Alzheimers research study may be provided at no cost to qualified participants. Contact us today. (800) NEW-STUDY | Syrentis.com #TargetTau1Study #EndALZ

The HOPE study is evaluating a new, wearable device to potentially treat or slow the progression of Alzheimer’s disease using sensory stimulation. Learn more. (800) NEW-STUDY | Syrentis.com #HOPEstudy #Alzheimers #EndALZ #ClinicalTrials #SyrentisClinicalResearch

September is #WorldALZMonth, and #TimeToActOnAlzheimers is now. Visit our clinic in Santa Ana for a FREE memory screening to assess cognitive decline and learn about how to improve your brain health. Learn more: (800) NEW-STUDY | Syrentis.com #WorldAlzheimersMonth

Research shows #Alzheimers disproportionately impacts people who are Hispanic, Black, and/or from rural communities. Join a #GAPNet site near you where we work to intentionally include diverse populations in clinical trials! tinyurl.com/GAP-Net-map #HispanicHeritageMonth #StopALZ